Omicron patients below 60 years can take paracetamol, says expert

People below 60 years of age with no comorbidities, infected by the Omicron variant, can begin their treatment with paracetamol, Dr Shashank Joshi, member of Maharashtra's Covid task force, said.

Omicron patients below 60 years can take paracetamol, says expert
IANS New Delhi
2 min read Last Updated : Jan 20 2022 | 9:00 PM IST

People below 60 years of age with no comorbidities, infected by the Omicron variant of Covid-19, can begin their treatment with paracetamol, Dr Shashank Joshi, member of Maharashtra's Covid task force, said.

In the latest episode of online show Health4All by Heal Foundation, Joshi, an endocrinologist at Lilavati Hospital in Mumbai, said that doctors are likely to prescribe antivirals like Molnupiravir, if someone above the age of 50 has a consistent fever for two days alongside two or three comorbidities.

But "Omicron patients below 60 years with no comorbidities can start symptomatic treatment with paracetamol", he said.

However, paracetamol should not be prescribed to children below the age of 18 years, to pregnant women, or to patients who require hospitalisation, he added.

Earlier, there were reports claiming that paracetamol 500 mg tablets were being given to children along with Covaxin -- the only approved Covid vaccine for teenagers in India.

Vaccine maker Bharat Biotech clarified that Paracetamol or painkillers are not recommended for teenagers after being vaccinated with Covaxin.

Further, Joshi recommended using paracetamol within 72 hours of the onset of symptoms "for patients in the high-risk population group, namely, hypertensives, diabetics, people on immunosuppressed medication, senior citizens, people with other ailments and likewise".

"Whenever we have a new disease which is constantly evolving, new treatment methods are also bound to come up. However, it is up to the doctors to identify the most vulnerable people and prescribe medication accordingly," he added.

--IANS

rvt/sks

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus TestsElderly populationparacetamol

First Published: Jan 20 2022 | 9:00 PM IST

Next Story